BioMark CEO Interview with SNNLive, Sep 2015
Stock News Now Interview In this SNNLive On-Location, our host spoke with Rashid Ahmed, President and CEO of BioMark Diagnostics Inc. (OTCQB: BMKDF) in New York City, NY.
BioMark Diagnostics presents at Rodman & Renshaw Conference in NY, USA
BioMark Diagnostics Inc. presents at Rodman & Reshaw Conference in New York, USA Follow these links for our audio presentation and corporate overview power point. Audio Presentation Powerpoint Presentation
BioMark AGM
BioMark is holding its Annual General and Special Meeting on September 17, 2015 at 925 W Georgia Street #1820, Vancouver, BC. We look forward to seeing you at the meeting. For more information, please visit SEDAR DOWNLOAD AGM MATERIALS FORM OF PROXY (PDF) NOTICE OF MEETING (PDF) MANAGEMENT INFORMATION CIRCULAR (PDF)
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung CancerDr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics to Conduct Validation Studies (PDF) ———————————————
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics to Conduct Validation Studies (PDF) ———————————————
Quest for Game Changing Lung Cancer Diagnostic Assay
HealthTech Innovation Hub and Surrey Memorial Hospital Rashid Ahmed, President & CEO Dr. James Bond, Chief of Thoracic Surgery, Surrey Memorial Hospital
BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer
Sept 9thBioMark Diagnostics Receives Clearance from Health Canada (PDF) ———————————————
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis_1 (PDF) ———————————————
BioMark Diagnostics to open U.S. headquarters in Maryland.
News and Events – 8/13/15 TOP STORY: Emergent Receives $44M from CDC Gaithersburg’s Emergent BioSolutions will receive $44M from the CDC in support of its role in the supply of VIGIV, a therapeutic licensed by FDA for the treatment of complications due to smallpox vaccination. Emergent also announced its plans to spin-off its […]
BioMark Diagnostics Unveils U.S. Strategy
Biomark US Strategy (PDF) ———————————————
